LianBio ADR Alpha and Beta Analysis
| LIANDelisted Stock | USD 2.18 0.05 2.24% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as LianBio ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in LianBio ADR over a specified time horizon. Remember, high LianBio ADR's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to LianBio ADR's market risk premium analysis include:
Beta (0.12) | Alpha 0.16 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
LianBio |
LianBio ADR Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. LianBio ADR market risk premium is the additional return an investor will receive from holding LianBio ADR long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in LianBio ADR. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate LianBio ADR's performance over market.| α | 0.16 | β | -0.12 |
LianBio ADR Fundamentals Vs Peers
Comparing LianBio ADR's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze LianBio ADR's direct or indirect competition across all of the common fundamentals between LianBio ADR and the related equities. This way, we can detect undervalued stocks with similar characteristics as LianBio ADR or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of LianBio ADR's fundamental indicators could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare LianBio ADR to competition |
| Fundamentals | LianBio ADR | Peer Average |
| Return On Equity | -0.32 | -0.31 |
| Return On Asset | -0.22 | -0.14 |
| Current Valuation | (182.65 M) | 16.62 B |
| Shares Outstanding | 108.06 M | 571.82 M |
| Shares Owned By Insiders | 5.90 % | 10.09 % |
| Shares Owned By Institutions | 78.99 % | 39.21 % |
| Number Of Shares Shorted | 378.13 K | 4.71 M |
LianBio ADR Opportunities
LianBio ADR Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About LianBio ADR Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including LianBio or other delisted stocks. Alpha measures the amount that position in LianBio ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
LianBio ADR Upcoming Company Events
As portrayed in its financial statements, the presentation of LianBio ADR's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LianBio ADR's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of LianBio ADR's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of LianBio ADR. Please utilize our Beneish M Score to check the likelihood of LianBio ADR's management manipulating its earnings.
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with LianBio ADR
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |